Methylphenidate and Central Precocious Puberty: A Probable Side Effect among Seven Children with the Attention Deficit Hyperactivity Disorder
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Methylphenidate (MPH) is the most preferred drug for treatment of the attention deficit hyperactivity disorder (ADHD). Here, we aimed to discuss the possible effects and mechanisms of MPH on precocious puberty (PP) via a case series with seven children who had normal body mass index. In this case series we evaluated seven children with ADHD, who had received MPH for at least 6 months (0.5 mg/kg/dose three times a day, maximum 60 mg) and admitted to Department of Pediatric Endocrinology with PP symptoms. The mean age was 8.16 years. Basal hormonal levels (luteinizing hormone [LH], follicle stimulating hormone, and estrogen/testosterone) were within normal range. Results of LH-releasing hormone stimulation tests demonstrated central pubertal responses. Glutamine, dopamine and noradrenaline are most important excitatory neurotransmitters that have a role at the beginning of puberty. The effect of MPH, cumulating dopamine and noradrenaline in the synaptic gap could be associated with the acceleration of puberty with the excitatory effect of dopamine’s gonadotropin-releasing hormone (GnRH) release, excitatory effect of noradrenaline’s GnRH release and the disappearance of GnRH receptor expression suppressor effect on prolactin disinhibitory effect.
Abstract
Methylphenidate (MPH) is the most preferred drug for treatment of the attention deficit hyperactivity disorder (ADHD). Here, we aimed to discuss the possible effects and mechanisms of MPH on precocious puberty (PP) via a case series with seven children who had normal body mass index. In this case series we evaluated seven children with ADHD, who had received MPH for at least 6 months (0.5 mg/kg/dose three times a day, maximum 60 mg) and admitted to Department of Pediatric Endocrinology with PP symptoms. The mean age was 8.16 years. Basal hormonal levels (luteinizing hormone [LH], follicle stimulating hormone, and estrogen/testosterone) were within normal range. Results of LH-releasing hormone stimulation tests demonstrated central pubertal responses. Glutamine, dopamine and noradrenaline are most important excitatory neurotransmitters that have a role at the beginning of puberty. The effect of MPH, cumulating dopamine and noradrenaline in the synaptic gap could be associated with the acceleration of puberty with the excitatory effect of dopamine’s gonadotropin-releasing hormone (GnRH) release, excitatory effect of noradrenaline’s GnRH release and the disappearance of GnRH receptor expression suppressor effect on prolactin disinhibitory effect.
참고문헌 (18)
- Polanczyk G, "The worldwide prevalence of ADHD : a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)
- Barkley RA, "The persistence of attention-deficit", hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder, 2002, pp.111, 279~289
- Gumy C, "Prevalence of methylphenidate prescription among school-aged children in a Swiss population : increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics", J Atten Disord, 14, pp.267~272 (2010)
- Kuczenski R, "Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine : comparison with amphetamine", J Neurochem, 68, pp.2032~2037 (1997)
- Montagnini BG, "Effects of repeated administration of methylphenidate on reproductive parameters in male rats", Physiol Behav, 133, pp.122~129 (2014)
- Vidal B, "Dopamine inhibits luteinizing hormone synthesis and release in the juvenile European eel : a neuroendocrine lock for the onset of puberty", Biol Reprod, 71, pp.1491~1500 (2004)
- Guarraci FA, "Exposure to methylphenidate during peri-adolescence affects endocrine functioning and sexual behavior in female Long-Evans rats", Pharmacol Biochem Behav, 142, pp.36~41 (2016)
- Poulton AS, "Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder", Med J Aust, 198, pp.29~32 (2013)
- Beaulieu JM, "The physiology, signaling, and pharmacology of dopamine receptors", Pharmacol Rev, 63, pp.182~217 (2011)
- Dickstein SG, "The neural correlates of attention deficit hyperactivity disorder : an ALE meta-analysis", J Child Psychol Psychiatry, 47, pp.1051~1062 (2006)
- Hopwood NJ, "Pathogenesis and management of abnormal puberty", Spec Top Endocrinol Metab, 7, pp.175~236 (1985)
- Adriani W, "Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual", endocrine parameters in male rats, 2006, pp.1074, 52~73
- Davison BA, "Hypothalamic biogenic amine levels in broiler chicks showing advanced sexual maturation", Poult Sci, 70, pp.1610~1618 (1991)
- Chatterjee-Chakrabarty S, "Adverse effects of methylphenidate on the reproductive axis of adolescent female rats", Fertil Steril, 84(Suppl 2), pp.1131~1138 (2005)
- Kelly BD, "Methylphenidate-induced erections in a prepubertal child", J Pediatr Urol, 9, pp.e1~e2 (2013)
- Bilgiç A, "Excessive masturbation and hypersexual behavior associated with methylphenidate", J Am Acad Child Adolesc Psychiatry, 46, pp.789~790 (2007)
- Coskun M, "A report of two cases of sexual side effects with OROS methylphenidate", J Child Adolesc Psychopharmacol, 19, pp.477~479 (2009)
- Levin GM, "Case report : development of precocious puberty in two children treated with clonidine for aggressive behavior", J Child Adolesc Psychopharmacol, 3, pp.127~131 (1993)